These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9439759)

  • 41. Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis.
    Verschuuren JJ; Graus YM; Theunissen RO; Yamamoto T; Vincent A; van Breda Vriesman PJ; De Baets MH
    J Neuroimmunol; 1992 Feb; 36(2-3):117-25. PubMed ID: 1732277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.
    Lennon VA; Lindstrom JM; Seybold ME
    J Exp Med; 1975 Jun; 141(6):1365-75. PubMed ID: 1127382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
    J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cells and cytokines in the pathogenesis of acquired myasthenia gravis.
    Milani M; Ostlie N; Wang W; Conti-Fine BM
    Ann N Y Acad Sci; 2003 Sep; 998():284-307. PubMed ID: 14592887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: correlated with cellular, humoral and clinical responses.
    Christadoss P; Lindstrom J; Munro S; Talal N
    J Neuroimmunol; 1985 Apr; 8(1):29-41. PubMed ID: 3973007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age-related susceptibility to experimental autoimmune myasthenia gravis: immunological and electrophysiological aspects.
    Hoedemaekers AC; Verschuuren JJ; Spaans F; Graus YF; Riemersma S; van Breda Vriesman PJ; De Baets MH
    Muscle Nerve; 1997 Sep; 20(9):1091-101. PubMed ID: 9270663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acetylcholine receptors and myasthenia gravis.
    Vincent A
    Clin Endocrinol Metab; 1983 Mar; 12(1):57-78. PubMed ID: 6303649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of experimental myasthenia with autologous idiotypes linked to muramyl dipeptide.
    Valderrama R; Eggers AE; Moomjy M; Kao PN; Michl J
    Clin Exp Immunol; 1988 Jul; 73(1):123-7. PubMed ID: 3168327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
    Gomez CM; Richman DP
    J Immunol; 1985 Jul; 135(1):234-41. PubMed ID: 3873489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.
    Levi G; Tarrab-Hazdai R; Teichberg VI
    Eur J Immunol; 1983 Jun; 13(6):500-7. PubMed ID: 6861875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of the target organ in determining susceptibility to experimental autoimmune myasthenia gravis.
    Hoedemaekers A; Bessereau JL; Graus Y; Guyon T; Changeux JP; Berrih-Aknin S; van Breda Vriesman P; De Baets MH
    J Neuroimmunol; 1998 Aug; 89(1-2):131-41. PubMed ID: 9726835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myasthenia gravis with anti-acetylcholine receptor antibodies.
    Meriggioli MN
    Front Neurol Neurosci; 2009; 26():94-108. PubMed ID: 19349707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-presynaptic membrane receptor antibodies in myasthenia gravis.
    Lu CZ; Link H; Mo XA; Xiao BG; Zhang YL; Qin Z
    J Neurol Sci; 1991 Mar; 102(1):39-45. PubMed ID: 1856731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of B-cells in experimental myasthenia gravis in mice.
    Wang HB; Li H; He B; Bakheit M; Levi M; Wahren B; Berglöf A; Sandstedt K; Link H; Shi FD
    Biomed Pharmacother; 1999 Jun; 53(5-6):227-33. PubMed ID: 10424244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
    Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Jul; 41(1):13-8. PubMed ID: 6777100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myasthenia gravis: the role of complement at the neuromuscular junction.
    Howard JF
    Ann N Y Acad Sci; 2018 Jan; 1412(1):113-128. PubMed ID: 29266249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.
    Hohlfeld R; Kalies I; Kohleisen B; Heininger K; Conti-Tronconi B; Toyka KV
    Neurology; 1986 May; 36(5):618-21. PubMed ID: 3486379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of an idiotype associated with antibodies responsible for neuromuscular dysfunction in rats with experimental autoimmune myasthenia gravis.
    Thompson PA; Edlund SA; Krolick KA
    Clin Immunol Immunopathol; 1995 Apr; 75(1):57-67. PubMed ID: 7882593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.